[Worldwide contraception].
La contraception à travers le monde.
Journal
Medecine sciences : M/S
ISSN: 1958-5381
Titre abrégé: Med Sci (Paris)
Pays: France
ID NLM: 8710980
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
entrez:
24
5
2022
pubmed:
25
5
2022
medline:
27
5
2022
Statut:
ppublish
Résumé
The latest statistics concerning contraceptive use in the world have been published in 2019 by the United Nations. Among the 1.9 billion of women of reproductive age (15-49 years), 1.1 billion have a need for family planning. Among them, 190 millions are not using any contraception, although they wanted to avoid a pregnancy. There is a significant discrepancy among continents concerning the percentage of contraceptive use and the distribution of the different types of contraception. Female sterilization is the most widespread method of contraception since it represents 24% of all contraception methods used. Male condoms is used by 21% of couples. Thus, progress is still needed to disseminate effective, well tolerated and potentially reversible methods of contraception. Education of females, couples, medical and paramedical staff is one of the priority targets to improve contraception throughout the world. La contraception à travers le monde. Les dernières données concernant la contraception à travers le monde ont été publiées en 2019 par l’Organisation des Nations unies (ONU). Parmi les 1,9 milliard de femmes en âge de procréer (entre 15 et 49 ans), 1,1 milliard souhaitaient une contraception. Pourtant, 10 % d’entre elles n’utilisaient pas de méthode contraceptive, essentiellement en raison d’un manque d’accès à ces méthodes. Selon les continents, une grande disparité est observée dans l’utilisation des différentes méthodes contraceptives. La stérilisation féminine, ou contraception définitive, reste cependant la méthode majoritairement utilisée puisqu’elle représente 24 % des contraceptions. Des progrès sont nécessaires, en particulier dans l’éducation, pour améliorer la diffusion d’autres méthodes également efficaces, qui sont bien tolérées et possiblement réversibles.
Autres résumés
Type: Publisher
(fre)
La contraception à travers le monde.
Identifiants
pubmed: 35608469
doi: 10.1051/medsci/2022058
pii: msc220058
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
457-463Informations de copyright
© 2022 médecine/sciences – Inserm.
Références
United Nations, Department of Economic and Social Affairs, Population Division (2019). Contraceptive Use by Method 2019: Data Booklet (ST/ESA/SER.A/435).
Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: Estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017 ; 49 : 7–16.
Islam MS, Afrin S, Jones SI, Segars J. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility. Endocr Rev 2020; 41(5) : bnaa012.
Curtis KM, Peipert JF. Long-Acting Reversible Contraception. N Engl J Med 2017 ; 376 : 461–468.
Moreau C, Bohet A, Le Guen M, et al. FECOND Group Unplanned or unwanted? A randomized study of national estimates of pregnancy intentions. Fertil Steril 2014 ; 102 : 1663–1670.
Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017 ; 49 : 7–16.
Bongaarts J, O’Neill BC. Global warming policy: is population left out in the cold?. Science 2018 ; 361 : 650–652.
https://www.guttmacher.org/united-states/abortion.
https://drees.solidarites-sante.gouv.fr/sides/default/files/2021-02/ER%201163.pdf.
https://drees.solidarites-sante.gouv.fr/sides/default/files/2021-09/ER1207_0.pdf.
Warasna B, Rajabi N, Mustafa B, et al. Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study. Lancet 2021; 398 : S45.
Kamijo K, Kataoka Y, Shigemi D. Challenges of accessing emergency contraceptive pills in Japan. BMJ Sex Reprod Health 2021; 47 : 232–3.
https://www.interieur.gouv.fr/Archives/Archives-des-dossiers/2017-Dossiers/Le-developpement-durable-au-ministere-de-l-Interieur/L-agenda-2030-de-l-ONU-les-Objectifs-Developpement-Durable.
Starrs AM, Ezeh AC, Barker G, et al. Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher-Lancet Commission. Lancet 2018 ; 391 : 2642–2692.
https///solidarites-sante.gouv.fr/IMG/pdf/strategie_nationale_sante_sexuelle.pdf.
Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 2012 ; 380 : 111–125.
Cleland J, Bernstein S, Ezeh A, et al. Family planning: the unfinished agenda. Lancet 2006 ; 368 : 1810–1827.
Tran NT, Seuc A, Coulibaly A, et al. Post-partum family planning in Burkina Faso (Yam Daabo): a two group, multi-intervention, single-blinded, cluster-randomised controlled trial. Lancet Glob Health 2019 ; 7 : e1109–e1117.
Toan Tran N, Seuc A, Tshikaya B, et al. Effectiveness of post-partum family planning interventions on contraceptive use and method mix at 1 year after childbirth in Kinshasa, DR Congo (Yam Daabo): a single-blind, cluster-randomised controlled trial. Lancet Glob Health 2020; 8 : e399–e410.
National Institute for Health and Care Excellence. Long-Acting reversible contraception: the effective and appropriate use of long-acting reversible contraception, 2005. https:// www.nice.org.uk/guidance/cg30/evidence/full-guideline-pdf194840607.
Pasvol TJ, McGregor EA, Rait G, Horsfall L. Time trends in contraceptive prescribing in UK primary care 2000–2018: a repeated cross-sectional study. BMJ Sex Repro Health 2021; bmjsrh-2021-201260.
Glasier A, Baraitser P, McDaid L, et al. Emergency contraception from the pharmacy 20 years on: a mystery shopper study. BMJ Sex Reprod Health 2021; 47 : 55–60.
Cameron ST, Glasier A, McDaid A, et al. Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial. Lancet 2020; 396 : 1585–94.
Ries Thurman A, Schwartz JL, Brache V, et al. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women. PLoS One 2018; 13 : e0199778.
Duffy DM. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum Reprod Update 2015 ; 21 : 652–670.
Glasier A.. Acceptability of contraception for men: a review. Contraception 2010 ; 82 : 453–456.
Long JE, Lee JE, Blithe DL. Novel Hormonal and Nonhormonal Male Contraceptive Development. J Clin Endocrinol Metab 2021; 106 : e2381–92.
Jain T, Schwarz EB, Mehrotra A. A study of telecontraception. N Engl J Med 2019 ; 381 : 1287–1288.
Sadeghi I, Byrne J, Shakur R, Langer R. Engineered drug delivery devices to address Global Health challenges. J Control Release 2021; 331 : 503–14.
Al Dalaty A, Gualeni B, Coulman S, Birchall J. Models and methods to characterise levonorgestrel release from intradermally administered contraceptives. Drug Deliv Transl Res 2022; 12 : 335–49.
Kirtane AR, Hua T, Hayward A, et al. A once-a-month oral contraceptive. Sci Transl Med 2019; 11 : eaay2602.